Systematic review of statins for the prevention of vascular dementia or dementia

Geriatrics and Gerontology International

Volumn 10, Issue 2, 2010, Pages 199-208

  Muangpaisan, Weerasak ^a,b   Brayne, Carol ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dementia; Prevention; Statins; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITION; DRUG EFFICACY; DRUG USE; FOLLOW UP; HUMAN; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

DEMENTIA, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 77952518561     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00579.x     Document Type: Article

References (31)

1. Dubois MF, Hebert R. The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology 2001, 20:179-187.
2. Lobo A, Launer LJ, Fratiglioni L. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54:S4-S9.
3. Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995, 14:240-257.
4. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004, 61:705-714.
5. Sonohara K, Kozaki K, Akishita M. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int 2008, 8:93-100.
6. Vernooij MW, Ikram MA, Vrooman HA. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009, 66:545-553.
7. Takato T, Yamada N, Ashida T. Effects of aging and sex on progression of carotid intima-media thickness: a retrospective 6-year follow-up study. Geriatr Gerontol Int 2008, 8:172-179.
8. Naito T, Sawabe M, Arai T. Dyslipidemia is a major determinant of systemic atherosclerosis in the elderly: an autopsy study. Geriatr Gerontol Int 2007, 7:229-237.
9. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998, 352:1801-1807. Eastern Stroke and Coronary Heart Disease Collaborative Research Group
10. Solomon A, Kareholt I, Ngandu T. Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging 2007, 68:751-756.
11. Moriguchi E, Yamori Y, Mori M. New beverage for cardiovascular health, proposal based on oriental and occidental food culture from a world-wide epidemiological study. Geriatr Gerontol Int 2008, 8(1):S3-S7. Suppl
12. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389. Scandinavian Simvastatin Survival Study Group
13. Sever PS, Dahlof B, Poulter NR. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003, 361:1149-1158.
14. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339:1349-1357. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
15. Amarenco P, Lavallee P, Touboul PJ. Statins and stroke prevention. Cerebrovasc Dis 2004, 17(1):81-88. Suppl
16. Di Mascio R, Marchioli R, Tognoni G. Cholesterol reduction and stroke occurrence: an overview of randomized clinical trials. Cerebrovasc Dis 2000, 10:85-92.
17. Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 2000, 35:1-10.
18. Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther 2007, 113:378-393.
19. Zhou B, Teramukai S, Fukushima M. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dement Geriatr Cogn Disord 2007, 23:194-201.
20. Scott H, Laake K. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev 2001, 4:CD003160.
21. Etminan M, Gill S, Samii A. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003, 23:726-730.
22. Khan K, Kunz R, Kleijnen J, Antes G. Systematic Reviews to Support Evidence-Based Medicine. How to Review and Apply Findings of Healthcare Research 2007, Oxford, The Royal Society of Medicine Press Ltd
23. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900.
24. Rea TD, Breitner JC, Psaty BM. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 2005, 62:1047-1051.
25. Zandi PP, Sparks DL, Khachaturian AS. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry 2005, 62:217-224.
26. Szwast SJ, Hendrie HC, Lane KA. Association of statin use with cognitive decline in elderly African Americans. Neurology 2007, 69:1873-1880.
27. Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008, 71:344-350.
28. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000, 356:1627-1631.
29. Li G, Higdon R, Kukull WA. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 2004, 63:1624-1628.
30. Cummings JL. Alzheimer's disease. N Engl J Med 2004, 351:56-67.
31. Sterne J, Egger M, Smith G. Investigating and dealing with publication and other biases. Systematic Reviews in Health Care. Meta-Analysis in Context 2007, 189-208. Egger M, Smith G, Altman D. In, eds., Cornwall, BMJ Publishing Group